The effect of exogenous insulin-like growth factor-I (IGF-I) on the reproductive performance of female rats, and on serum concentrations of endogenous IGF-I and IGF-I binding proteins.
The effect of exogenous IGF-I on the reproductive performance of female rats was examined by infusing either recombinant human IGF-I (400 micrograms/d; n = 19) or vehicle (n = 18) over a four-day period (the time of one reproductive cycle) beginning on the day following estrus. The females were exposed to male rats one day after the infusions had commenced, and were euthanized 15 d later. There was no treatment effect on serum progesterone levels at this time or on the number of fetuses. Furthermore, the number of corpora lutea were not different between the IGF-I and vehicle infused groups (15.8 vs. 14.8; P = 0.09). Total serum IGF-I concentrations, as determined with a polyclonal antiserum based RIA, were increased approximately three-fold in samples obtained 20 hr after commencing the IGF-I infusion. These samples were also analyzed for IGF-I with a monoclonal antibody based RIA previously shown to detect human, but not rat, IGF-I. By subtraction, the concentration of endogenous rat IGF-I was found to be approximately 60% higher in IGF-I-infused rats than in control rats. This increase was likely due to a reduced clearance rate of IGF-I from the circulation, caused by a marked induction of 42-46 kDa and 30-34 kDa IGF-I binding proteins observed in these samples with a ligand blot technique. The binding protein induction indicates that the infused IGF-I was bioactive. This induction may have attenuated the effects of IGF-I on ovarian function.
Kerr
D E
DE
Department of Animal and Poultry Science, University of Saskatchewan, Saskatoon, Canada.
Kirkwood
R N
RN
D000704:Analysis of Variance; D000818:Animals; D002352:Carrier Proteins / Q000097:blood*; D003720:Densitometry; D005260:Female; D005298:Fertility / Q000187:drug effects; D015151:Immunoblotting; D015918:Infusion Pumps, Implantable; D018969:Insulin-Like Growth Factor Binding Proteins; D007334:Insulin-Like Growth Factor I / Q000008:administration & dosage / Q000032:analysis / Q000494:pharmacology*; D008024:Ligands; D008098:Litter Size / Q000187:drug effects; D011374:Progesterone / Q000097:blood; D051381:Rats; D011919:Rats, Inbred Strains; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology; D012098:Reproduction / Q000187:drug effects*
D002352:Carrier Proteins; D018969:Insulin-Like Growth Factor Binding Proteins; D008024:Ligands; D011994:Recombinant Proteins; D011374:Progesterone; D007334:Insulin-Like Growth Factor I